Q3 2018 Holdings
Filed 2018-11-13 | 10 holdings | $1.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Rubius Therapeutics Inc | COM | 78116T103 | $919.1K | 38,296,526 | 60.7% |
| Evelo Biosciences Inc | COM | 299734103 | $222.1K | 18,233,403 | 14.7% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $193.9K | 8,918,749 | 12.8% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $96.3K | 12,682,876 | 6.4% |
| Quanterix Corp(QTRX) | COM | 74766Q101 | $43.5K | 2,030,495 | 2.9% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $38.2K | 3,204,437 | 2.5% |